Aug 14, 2026 04:11PM
May 15, 2026 03:51PM
Mar 30, 2026 10:00PM
Dec 30, 2025 04:30PM
Dec 30, 2025 04:30PM
Nov 14, 2025 03:57PM
Aug 14, 2025 03:13PM Emmaus Life Sciences Reports Quarterly Financial Results
Jun 26, 2025 09:30AM
Jun 26, 2025 09:30AM
May 15, 2025 04:30PM
Apr 14, 2025 06:25PM
Jan 29, 2025 09:30AM
Nov 19, 2024 05:00PM
Sep 10, 2024 02:15PM Emmaus Life Sciences Reports Quarterly Financial Results
Jul 12, 2024 10:00AM
Jul 3, 2024 09:00AM
Apr 15, 2024 04:07PM
Feb 2, 2024 10:00AM
Nov 14, 2023 09:30AM
Aug 23, 2023 09:00AM
Aug 14, 2023 03:54PM Emmaus Life Sciences Reports Q2 2023 Financial Results
May 31, 2023 02:11PM
May 15, 2023 09:30AM
Nov 14, 2022 06:17PM
Sep 28, 2022 06:30AM
Aug 15, 2022 04:30PM
May 13, 2022 08:23AM
Apr 26, 2022 08:23AM Emmaus Life Sciences to Present at Investor Conferences in May
Apr 7, 2022 08:23AM
Mar 31, 2022 05:24PM
Mar 23, 2022 08:24AM
Mar 23, 2022 08:23AM
Mar 4, 2022 08:23AM
Dec 14, 2021 08:23AM
Dec 6, 2021 08:23AM Emmaus Life Sciences' Data on Endari® Accepted for Poster Presentation at the 63rd American Society of Hematology Annual Meeting & Exhibition
Nov 12, 2021 08:23AM
Nov 11, 2021 08:23AM
Nov 4, 2021 08:23AM
Oct 26, 2021 08:23AM
Aug 2, 2021 09:04AM
Aug 2, 2021 09:00AM
Jun 15, 2021 11:21AM Emmaus Life Sciences Announces Submission of Marketing Authorization Application to Swissmedic Ideogen, A.G. to Manage Early Access Program
May 4, 2021 09:30AM
Mar 2, 2021 11:44AM
Jan 25, 2021 12:13PM
Dec 10, 2020 11:30AM
Dec 8, 2020 11:30AM
Dec 3, 2020 11:20AM
Nov 10, 2020 11:25AM Emmaus Life Sciences Submits Temporary License Application in Bahrain for Endari®
Nov 3, 2020 11:30AM

329,074 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All